PubMed: THE ACUTE EFFECTS OF CANNABIS WITH AND WITHOUT CANNABIDIOL IN ADULTS AND ADOLESCENTS: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER EXPERIMENT
Addiction. 2023 Feb 7. doi: 10.1111/add.16154. Online ahead of print.
BACKGROUND AND AIMS: Long-term harms of cannabis may be exacerbated in adolescence, but little is known about the acute effects of cannabis in adolescents. We aimed to: (1) compare the acute effects of cannabis in adolescent and adult cannabis users, and (2) determine if cannabidiol (CBD) acutely modulates the effects of delta-9-tetrahydocannabinol (THC).
DESIGN: Randomised, double-blind, placebo-controlled, crossover experiment. The experiment was registered on ClinicalTrials.gov (NCT04851392).
SETTING: Laboratory in London, United Kingdom.
PARTICIPANTS: Twenty-four adolescents (12 women, 16-17 year-olds) and 24 adults (12 women, 26-29 year-olds) who used cannabis 0.5-3 days/week and were matched on cannabis use frequency (mean=1.5 days/week).
INTERVENTION: We administered three weight-adjusted vaporised cannabis flower preparations: ‘THC’ (8mg THC for 75kg person); ‘THC+CBD’ (8mg THC and 24mg CBD for 75kg person); and ‘PLA’ (matched placebo).
MEASUREMENTS: Primary outcomes were: i) subjective ‘feel drug effect’; (ii) verbal episodic memory (delayed prose recall); and (iii) psychotomimetic effect (Psychotomimetic States Inventory).
FINDINGS: Compared with ‘PLA’, ‘THC’ and ‘THC+CBD’ significantly (p<0.001) increased ‘feel drug effect’ (mean difference (MD)=6.3, 95% confidence interval (CI) 5.3 to 7.2; MD=6.8, 95% CI 6.0 to 7.7), impaired verbal memory (MD=-2.7, 95% CI -4.1 to -1.4; MD=-2.9, 95% CI -4.1 to -1.7), and increased psychotomimetic effects (MD=7.8, 95% CI 2.8 to 12.7; MD=10.8, 95% CI 6.2 to 15.4). There was no evidence that adolescents differed from adults in their responses to cannabis (interaction p≥0.4). Bayesian analyses supported equivalent effects of cannabis in adolescents and adults (BF01 >3). There was no evidence that CBD significantly modulated the acute effects of THC.
CONCLUSIONS: Adolescent cannabis users are neither more resilient nor more vulnerable than adult cannabis users to the acute psychotomimetic, memory-impairing, or subjective effects of cannabis. Furthermore, in adolescents and adults, vaporised cannabidiol does not mitigate the acute harms caused by delta-9-tetrahydocannabinol.
PMID:36750134 | DOI:10.1111/add.16154
https://pubmed.ncbi.nlm.nih.gov/36750134/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1NqsX9BbHlDygQ8TcgAlJilHgPpiuKQtyIr–a3-xbLzPoB9xM&fc=20220928170152&ff=20230208152313&v=2.17.9.post6+86293ac February 7, 2023 11:00 am